Blood test ratio may predict heart attack recovery, study finds
NCT ID NCT07076732
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 80 people who had a heart attack but no major blockages in their heart arteries (called MINOCA). Researchers checked if the ratio of white blood cells to a platelet marker in their blood could predict short-term health outcomes. The goal was to see if this simple blood test could help doctors understand recovery better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This case-control study will be performed at Sohag University Hospitals after approval from the institutional ethical committee.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years old. * Both sexes. * Patients with acute myocardial infarction (AMI). Myocardial infarction with nonobstructive coronary arteries (MINOCA) is diagnosed if a patient fulfilled the AMI criteria in the absence of obstructive coronary arteries (type I: \<50% stenosis; or type II: no stenosis) as recommended by the recent American Heart Association statement that introduces an updated definition incorporating the 4th universal MI definition, which by agreement excludes Takotsubo syndrome and myocarditis from the eventual diagnosis of MINOCA. Exclusion Criteria: * Previous history of MI or coronary revascularization (PCI or bypass surgery) with acute/chronic infection. * Autoimmune diseases. * Systemic inflammatory disease. * Patients on treatment therapy which critically affects inflammatory cell count. * Patients with malignancy. * Chronic kidney disease. * Severe liver disease. * Severe anemia. * Fever (\>38°C).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mean platelet volume are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag University
Sohag, 82511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Pharmacist and coach team takes aim at blood pressure after stroke
- Broken heart syndrome: is it as deadly as a heart attack?
- Fat graft may mend heart scars after a heart attack
- A simple breath test after a heart attack could prevent dangerous bleeding
- A simple ultrasound test may sharpen heart attack risk predictions